In the clinical setting it has been shown that acti vation will increase cerebral glucose uptake in excess of cere bral oxygen uptake. To study this phenomenon further, this study presents an experimental setup that enables precise de termination of the ratio between cerebral uptake of glucose and oxygen in the awake rat. Global CBF was measured by the Kety-Schmidt technique, and the ratio between cerebral uptake rates for oxygen, glucose, and lactate was calculated from ce rebral arterial-venous differences. During baseline conditions, rats were kept in a closed box designed to minimize interfer ence. During baseline conditions CBF was 1.08 ± 0.25 mL'g-I'minute-l , and the cerebral oxygen to glucose uptake ratio was 5.5. Activation was induced by opening the sheltering Cerebral activation increases cerebral glucose uptake out of proportion to cerebral oxygen uptake (Fox et aI.,
box for 6 minutes. Activation increased CBF to 1.81 mL· g-l·minute-I. During activation cerebral glucose uptake increased disproportionately to cerebral oxygen uptake, and the cerebral oxygen to glucose uptake ratio was 4.2. The accumu lated excess glucose uptake during 6 minutes of activation amounted to 2.4 j-Lmol/g. Activation was terminated by closure of the sheltering box. In the postactivation period, the cerebral oxygen to glucose uptake ratio rose to a maximum of 6.4. This response is exactly opposite to the excess cerebral glucose up take observed during activation. Key Words: Activation Cerebral oxygen metabolism-Cerebral glucose metabolism Lactate-Rat-Uncoupling. Villringer and Dirnagl, 1995; Frahm et aI., 1996) , it has never been verified by direct observations, and the meta bolic fate of activation-induced excess glucose uptake remains unknown. Although the experimental setting of fers some important advantages, all data addressing ac tivation-induced uncoupling of cerebral oxygen and glu cose uptake has been obtained in humans. A main pur pose of this study was therefore to establish a technique that enables simultaneous determination of cerebral glu cose and oxygen uptake in the awake rat. In a recent study on humans by our group it was shown that cerebral uptake of glucose in excess of cerebral oxygen uptake persists after cessation of the activation task (Madsen et aI., 1995a) . In that study cerebral uptake rates were monitored for 40 minutes after activation, at which time excess glucose uptake was still manifest. Knowledge re garding excess glucose uptake in the postactivation pe riod is thus incomplete. A second major purpose of this study was therefore to achieve a detailed description of the ratio of cerebral glucose and oxygen uptake in the postactivation period.
METHODS

Animals and surgical procedures
Normal male Sprague Dawley rats (M011egaarden, Lille Skensved, Denmark) weighing 336 to 550 g were maintained on an alternate 12-hour light/dark cycle with humidity con trolled at normal levels. Access to water and food was unlim ited. All procedures performed on animals were in strict accor dance with the National Institutes of Health Guide for Care and Use of Laboratory Animals and were approved by The Danish Animal Experiment Expectorate.
To accustom the animal to the experimental setting. they spent a minimum of I day in their cages in the laboratory setting. To stabilize arterial glucose levels during activation, rats were fasted for approximately 20 hours before the experi ment. Access to water was unrestricted. On the experimental day the animal was anesthetized with halothane (4% for induc tion and 1. 5% for maintenance) in 70% N20/30% °2, and polyethylene catheters (length 18 cm, PE 50, Portex, Hythe, Kent, U.K.) filled with physiologic saline with 20 units of sodium heparin per milliliter were inserted in both femoral arteries and femoral veins. The surgical incisions were closed and infiltrated with lidocaine/prilocaine (EMLA cremc, Astra, SOdertiilje, Sweden). Cerebral venous blood was obtained through a catheter that was inserted into the confluence of sinuses through a screw placed just posterior to the lambdoid suture. The cerebral venous catheter was identical to the cath eters inserted in the femoral vessels. A plaster cast was applied around the lower torso for restraint, and an average of 3 hours 28 minutes (range 3 hours 4 minutes to 4 hours 31 minutes) was allowed before initiating experimental procedures. In the re covery period, the rat was kept in a shelter specially designed to minimize external stimulation. The shelter was a closed tri angular box with apertures permitting passage of blood sample catheters. In the shelter. the rat was monitored by closed circuit video surveillance, and air change was assured by a small ven tilator. Rectal temperature was monitored with a rectal probe, and MABP was continuously measured with a pressure trans ducer connected to one of the arterial catheters.
Ex p erimental p rotocols
Measurements were performed during three different condi tions. Blood samples before activation were obtained with the animal remaining in the closed sheltering box. External stimu lation was kept at a minimum. Activation was induced by open ing of the shelter, exposing the rat to the environment. No further activation procedures were performed. After 6 minutes, the shelter was closed, and blood samples in the postactivation period were obtained exactly as before activation.
Cerebral arterial-venous differences jor oxygen, glucose, lactate and r3-hydroxybutyrate. Blood for determination of ce rebral arterial-venous differences for oxygen [(a-v) 02], glu cose [(a-v) g lcJ, and lactate [(a-v)laJ was obtained from a single paired blood sample. The volumes of the arterial and cerebral venous catheter systems were 0.055 mL, and before blood sam pling a dead-space volume of 0. 150 mL blood was drawn. Immediately after this 0.30 mL of blood was drawn into ice cold O.5-mL glass Microliter Syringes (Hamilton Bonaduz AG, Bonaduz, Switzerland) prepared with heparin and NaP. The rate of sampling was the same from the arterial and the cerebral venous catheters and in all cases lower than 0.57 mLiminute. After completion of each paired blood sample, blood loss was replaced by systemic intravenous injection of blood obtained from a donor rat. Immediately after sampling, 0. 18 mL blood for determination of whole blood glucose and lactate concen trations were transferred to vials containing dried tluoride EDTA; these vials were stored on ice and analyzed in quadru plicate within 60 minutes on a YSI 2700 Select Biochemistry Analyzer (Yellow Springs Instruments Co. Inc. , Yellow Springs, Ohio, U. S.A.). Approximately 0. 12 mL blood for de termination of (a-v)o2 were stored on ice under strict anaerobic conditions and analyzed in triplicate within 40 minutes on an OSM3 apparatus (Radiometer, Copenhagen, Denmark). Blood for determination of cerebral arterial-venous differences for r3-hydroxybutyrate (r3-0HB) [(a-v) ro _ OI l B l was sampled in ice cold 5-mL glass Microliter Syringes (Hamilton Bonaduz AG) prepared with heparin and NaF. The blood sample volume was 2. 5 mL, and samples was handled and measured as described by Williamson et al. (1962) . During the blood sampling pro cedure, blood loss was continuously replaced by blood obtained from a donor rat. A total of 31 animals were investigated. Measurements were performed according to five different pro tocols.
Cerebral (a-v) differences during baseline conditions. In this series 12 consecutive determinations of (a-v) g le, (a-v)o2'
and (a-v)lac were obtained with the experimental animals (n = 6) remaining in the sheltering box. The schedule for blood sampling is shown in Fig. I .
Cerebral (a-v) differences before, during, and after ac tivation. Twelve consecutive determinations of (a-v)02, (a-v) g lc' and (a-v)la e were obtained in six rats during three dif ferent conditions: an 8-minute preactivation period (four deter minations), 6 minutes of cerebral activation (three determina tions), and a 13-minute postactivation period (five determina tions) ( Fig. 2) .
Cerebral (a-v) differences before, during, and after ac tivation-prolonged period of measurement. In this series, the period of measurement after activation was prolonged. Two blood samples were obtained before activation, and two blood samples were obtained during 6 minutes of activation. In the 60 minutes after activation, eight paired blood samples were ob tained ( Fig. 3 ). Six rats were investigated.
Cerebral (a-v) differences for P-OHB. In this series, a single determination of (a-v) ro -OH H was performed before ac tivation, at 6 minutes of activation, and 25 minutes after ces sation of activation. Seven rats were investigated. Paired blood samples for determination of (a-v)o2' (a-v) g k' and (a-v) ' ac were obtained just before and just after completion of the blood samples for (a-v) i3 -0H B '
Cerebral (a-v) differences during glucose infusion. Acti vation increases the arterial glucose concentration. To study the isolated effect of increasing arterial glucose concentrations we determined (a-v)o2' (a-v) g lc' and (a-v)'ac during glucose infu sion but without activation. In this series the rat remained in the shelter throughout the study. After four paired blood samples, arterial glucose concentration was gradually elevated by infu sion of an isotonic glucose solution. Intravenous glucose was given during an II-minute period during which five paired blood samples were obtained. In the first 10 minutes after in fusion three blood samples were obtained. Six rats were inves tigated.
Determination of global cerebral blood flow. In eight rats global CBF was determined twice, one time during preactiva tion conditions and one time during activation. Global CBF was measured with a modification of the Kety-Schmidt technique. A detailed description of the procedure will be given else where; in brief the methodological approach can be described as follows. The brain was saturated by intravenous infusion of 1 33Xe dissolved in saline at a constant rate of approximately 2.5
MBq/minute. After 30 minutes of constant 1 33Xe infusion, three paired blood samples were obtained from the arterial and cerebral venous catheters. Infusion with 133Xe was terminated, and during the first 9 minutes of tracer desaturation arterial and cerebral venous blood was sampled at a constant rate of 0.50 mLiminute, using a mechanical withdrawal pump (model 55-2226, Harvard Apparatus, South Natick, MA, U.S.A.). After completion of continuous blood sampling, paired blood samples were obtained from the two catheter systems. The concentration of 133Xe in the blood samples was determined in a gamma counter (Packard Auto-Gamma Cobra II, Meridian, CT, U.S.A.), and CBF was calculated using a slightly modified version of the Kety-Schmidt equation:
where sand d signify tracer concentration in blood samples obtained before and after the period of continuous blood sam pling, and A denotes the blood to brain partition coefficient for Xel33 in whole rat brain (Gjedde et aI., 1975) . In the denomi nator, a and v denote tracer concentrations in arterial (a) and cerebral venous (v) blood obtained during t minutes of desatu ration. The period of activation was 6 minutes when (a-v) g 1 c' press global CBF in the initial 5 to 6 minutes of the measure ment period.
Calculations
Cerebral (a-v)o2 was calculated by multiplying the differ ence between oxygen saturation in arterial and cerebral venous blood with the hemoglobin concentration (Hb). Values for (a V) g lc' (a-v)lac, and (a-v) I3 �O H B were calculated from glucose, lactate, and 13-0HB determined in arterial and venous whole blood. The proportion of glucose uptake being oxidized was calculated as the oxygen-glucose index (OGI), where OGI = 100 (a-v)o2/6(a-v) g lc (%), (Cohen et aI., 1964) . The proportion of glucose uptake appearing as lactate in cerebral venous blood was calculated as the lactate-glucose index (LGI), where LGI = -100 (a-v)lac/2(a-v) g lc (%) (Cohen et aI., 1964) . The oxi dation of 1 mole of glucose requires 6 moles of oxygen, and the oxidation of 1 mole of 13-0HB requires 4.5 moles of oxygen (Ruderman et aI., 1974; Hasselbalch et aI., 1996) . From these values, the cerebral oxygen to glucose uptake ratio as corrected for cerebral uptake of 13-0HB was calculated from (a-v)o2' (a-v) g lc, and (a-v) I3 �HB. For each experimental condition, base� line, activation, and postactivation, values obtained with the five different experimental protocols were almost identical. To summarize results, cerebral arterial-venous differences deter� mined during identical conditions (i.e., before, during, and after activation) were summarized in a single table (Table I) . Global cerebral uptake rates for oxygen (CMRo2, glucose (CMR g 1 c), lactate (CMR1ac)' and 13-0HB (CMR I3 �OHB) were calculated according to the Fick principle (Kety and Schmidt, 1948) . In the calculation, the grand mean values for (a-v)o2' (a-v) g lc' Values (mean ± SD). The values represent the mean of values obtained in 31 animals. These animals were studied during identical conditions but with five different experimental protocols as described in the Methods section. The baseline value represent the mean of all measurements performed during baseline conditions in protocol 1-5 (137 measurements in 31 animals). The activation value represent the mean of all values obtained during activation in protocol 2-4 (37 measurements in 19 animals). PA(O-20) represent the mean of values obtained 0-20 minutes after cessation of activation in protocol 2 and 3 (38 measurements in 12 animals). PA(20-60) represents the mean of values obtained 20-60 minutes after activation with protocol 3-4 (37 measurements in 13 animals). Statistical significance are denoted by: *p < 0. 05; tP < 0.01. LGI. lactate glucose index; OGI. oxygen glucose index; PA. protocol activation.
(a-v) J ac ' and (a-v) i3 -0 HB listed in Table 1 were multiplied with the values for CBF obtained in the second part of the study. A paired Student ' s t test was used in the statistical evaluation of data comparing baseline values with values obtained during activation. and with data obtained during the early (0 to 20 minutes) and late (20 to 60 minutes) part of postactivation. For each variable a total of three comparisons were performed. To compensate for this a Bonferroni correction was applied. A Bonferroni corrected probability value of P < 0.05 was con sidered significant.
RESULTS
Values obtained before activation
Values for physiologic values determined before acti vation were all within the normal range (Table 1) . Values for cerebral arterial-venous differences are listed in Table l . Before activation, the mean OGr was 103%± l8%(mean ± SD), and the mean LGI was 5%± 4%. The cerebral oxygen to glucose ratio as corrected for cerebral uptake of f3-0HB was 5.5. In the experimental series in which 12 consecutive blood samples were obtained with the rat remaining in the sheltering box, all measured values remained constant (Figure 1) . Before activation, the cerebral blood flow was 1.08 ± 0.25 mL'g-1 'minute-1 , and the calculated values for CMRo2 and CMR g \c were 3.92 fLmol'g-I 'minute-l and 0.66 fLmol'g-I )'minute-l , respectively. Values for CMRlac and CMR f3 _OH B are listed in Table 2 .
Values obtained during activation
Activation increased MABP (P < 0.01), Hb (P < 0.01), and the arterial concentrations of glucose (P < 0.05) and lactate (P < 0.01). Paco2 was reduced (P < 0.05) during activation (Table 1) . Activation reduced (a-v)o2 and (a v) g \c by 45% (P < 0.01) and 24% (P < 0.01), respectively.
The cerebral arterial-venous difference for lactate was positive during activation (Table 1) . During activation, the OGI was reduced to 86% ± 13% (P < 0.01) and the LGI was reduced to -4% ± 14% (P < 0.01). The cerebral oxygen to glucose ratio as corrected for cerebral uptake of f3-0HB was 4.2. These changes took place within the first minutes of activation and remained stable through out the 6-minute activation period (Figure 2 ). Activation increased CBF by 60% to a value of l.81 ± 0.55 mL'g-I 'minute- Values obtained 0 to 20 minutes after activation
In the early postactivation period values were partially normalized ( Table I ). The OGI remained reduced (P < 0.0 I) ( Figure 2 ). During this period, the arterial glucose Cerebral blood flow and cerebral uptake rates for oxygen (CMR02). glucose (CMF g I J. lactate (CMRlaJ. and i3-0HB (CMR p _OHB) ' Cere bral blood flow values represent values determined in the second part of the study (n = 8). statistical significance are denoted by: *p < 0.05. Cerebral uptake rates was calculated as the product of CBF and the mean values for (a-v)02' (a-v) g lc. (a-v)lae, and (a-v) p _OHB listed in Table  l . As uptake rates were calculated as the product of two mean values. no value for SD are given. and no statistical analysis could be per formed.
concentration reached its maximum, being 1.2 mmol/L higher than before activation (P < 0.0 1).
Values obtained 20 to 60 minutes after activation With the exception of the 001, all values were nor malized in the latter part of the postactivation period (Table 1 ). In the late postactivation phase, changes in the 001 were the opposite of what was observed during activation (Figure 3 ) and the 001 was 109% ± 24% (P < 0.05). The cerebral oxygen to glucose ratio as corrected for cerebral uptake of 13-0HB was 6.0, reaching a maxi mal value of 6.4 approximately 40 minutes after the shel tering box was closed (Figure 3) .
Cerebral (a-v) differences during glucose infusion
Infusion of glucose increased the arterial glucose con centration by 1.26 ± 0.28 mmol/L. The arterial lactate concentration increased slightly (P < 0.05), while Hb was slightly reduced (p < 0.0 I). No other value measured in the study series was changed by glucose infusion. The cerebral OOT was 103% ± 15% before infusion, and 100% ± 12% during infusion.
DISCUSSION
In the clinical setting cerebral activation will increase cerebral glucose uptake in excess of cerebral oxygen consumption. The data from the present study indicate that this also applies to the experimental setting. Tn the recovery period after activation we observed cerebral oxidative metabolism in excess of cerebral glucose up take. This is opposite to what we observed during acti vation and indicates that at least part of the activation induced excess glucose is released during recovery.
Baseline
Data from the study series in which 12 consecutive blood samples were obtained with the rat kept in the sheltering box remained stable, indicating that interfer ence from experimental procedures was minimal ( Figure   1 ). The physiologic variables obtained before activation are in close accordance with values obtained elsewhere during nonstressed conditions (Sokoloff et aI., 1977; Carlsson et aI., 1977; Siesjo, 1978;  Ohajar et a!., 1982;
Keykhah et a!., 1985; Dienel et aI., 1990; Adachi et aI., 1995; Horinaka et aI., 1997) . We therefore conclude that our rats, before activation, were in a nonactivated behav ioral state, and the baseline condition will in the follow ing be defined as the state of the animal when remaining in the closed shelter before activation. Ratios between (a-v\1c' (a-v)oz, and (a-v) l ac equal ratios between cere bral uptake rates for glucose, oxygen, and lactate. Deter mination of these cerebral arterial-venous differences therefore permits calculation of the proportion of cere bral glucose uptake that is oxidized (001) or lost as lactate in cerebral venous blood (LOI). During baseline J Cereh Blood Flow Metah, Vol. IX, No. 7, 1998 conditions, the 001 was 103%, and the LOI was 5% ( Table I) . The sum of the two indices being 108% sig nifies that the amount of carbon in glucose that was oxidized or escaped the brain as lactate was larger than the cerebral carbon uptake from glucose. This is caused by the period of starvation imposed on our rats before the experiment. During starvation the arterial concentration of ketone bodies increases, and ketone bodies, mainly 13-0HB, becomes an alternative substrate for oxidative metabolism (Hawkins et aI., 1971 (Hawkins et aI., , 1973 (Hawkins et aI., , 1986 Ruder man et aI., 1974; Ojedde and Crone, 1975; Kante et aI., 1990; Pollay and Stevens 1980) . To quantify the contri bution from cerebral ketone body metabolism, we deter mined arterial-venous differences 13-0HB. During base line conditions, the arterial-venous difference for 13-OHB was 0.07 ± 0.20 mmollL. Oxidation of 1 mole of 13-0HB requires 4.5 moles of oxygen (Ruderman et a!., 1974; Hasselbalch et aI., 1996) , and if oxygenation of 13-0HB is accounted for, the cerebral carbon uptake from glucose and 13-0HB almost perfectly correspond to the amount of carbon being oxidized or appearing as lactate in cerebral venous blood. Although other substances (e.g., a-ketoglutarate, acetoacetate, glycerol) are taken up by the brain, their quantitative contribution to brain metabolism is minor (see Kety, 1957) , and our data in dicate that cerebral carbon uptake during baseline con ditions is almost perfectly balanced by cerebral carbon oxygenation and cerebral lactate release.
Activation
Opening the sheltering box was associated with arousal. The experimental animal became active and dis played explorative behavior. Arterial glucose and MABP increased whereas P aco2 was reduced. Tn the following discussion we will therefore define activation as the be havioral state imposed on the animal by opening of the sheltering case. The arterial lactate concentration in creased markedly during activation. The activation pro cedure was associated with motor activity, and the acti vation-induced increase of arterial lactate is probably caused by anaerobic lactate production in skeletal muscles. In a previous study by our group we studied cerebral metabolism in human volunteers who were stimulated by the Wisconsin card sort test (Madsen et aI., 1995a) . In that study physical activity during activation was minimal, and the arterial lactate concentration re mained practically unchanged during activation. The ac tivation-induced increases in CBF, CMRo2, and CMR g l c were disproportional as CBF and CMR g lc increased more than CMRo2. Owing to these changes, the cerebral 001 was reduced during activation (Table I; Figures 2, 3) .
The magnitude of activation-induced excess glucose up take observed in this study is lower than values from studies on humans (Fox et aI., 1988; Ribeiro et aI., 1993; Fellows et aI., 1993; Frahm et aI., 1996) . The reason for this is probably that almost all human studies have been obtained with positron emission tomography, which en ables selective determination of excess glucose in the activated regions of the brain. In the present study in which global values are obtained, we also measured me tabolism in regions that remain inactivated. This will mask the magnitude of the activation response. In the only human study reporting global values, the magnitude of activation-induced excess glucose uptake was lower than in the present study (Madsen et aI., 1995a) . From the successive sample series it is evident that the cerebral oxygen-glucose index was reduced within the first min utes of activation, and that it remained low during the remaining part of the activation period ( Figure 2 ). During activation, the oxygen-glucose index was 86% ± 13% and the LGI was -4% ± 14% ( can be calculated that carbon from glucose equivalent to 2.4 fLmol glucose/g brain tissue would accumulate in the brain during the 6-minute activation period.
In another study with an almost identical experimental setup, and with similar activation-induced changes in ce rebral arterial-venous differences, we have observed an activation-induced 20% reduction in cerebral glycogen content (Madsen et aI., 1995b) . Adding the glucose car bon originating from a reduction of the cerebral glycogen pool would further increase the activation-induced in crease of the cerebral content of glucose intermediary substrates.
Postactivation
Cerebral glucose uptake remained higher than cerebral glucose oxidation for about 20 minutes after activation (Figure 2) . Such a persistent excess glucose uptake has also been observed in humans (Madsen et aI., 1995a) .
Approximately 20 minutes after cessation of activation, however, we observed exactly the opposite of what was observed during activation. During this period, the cere bral carbon uptake from glucose and [3-0HB was too small to account for oxidation and cerebral lactate efflux. Our data thus indicate that the later postactivation phase is associated with a net flux of glucose carbon from the brain. Taken together our data indicate that part of the activation-induced increase in cerebral glucose uptake is accumulating in the brain during the activation period and subsequently released during the recovery phase.
Comment
The data from the present study does not identify the metabolic pools in which glucose carbon accumulates during activation. According to the lactate hypothesis excess carbon uptake would be converted to lactate. If this was the case the 2.4 fLmol/g of glucose accumulating in the brain during activation would be converted to 4.8 fLmol/g of lactate. This increase is more than fourfold higher than the lactate increase of approximately 1 fLmol/g that was observed during similar conditions in another study by our group (Madsen et aI., 1995b) . The available data thus imply that conversion to lactate fails to account for activation-induced excess glucose uptake. The maximal increase in the arterial glucose concentra tion during activation was 1.0 ± 0.6 mmol/L (range 0.45 to 1.39 mmollL). The cerebral glucose content will in crease with the arterial glucose concentration, and excess glucose uptake could be caused by accumulation of un phosphorylated glucose in the brain. To evaluate this possibility we determined cerebral arterial-venous dif ferences during glucose infusion but without activation. Although glucose infusion increased the arterial glucose concentration by 1.26 ± 0.29 mmollL, the cerebral OGI remained virtually unchanged, and our data indicate that the activation-induced excess glucose uptake is caused by mechanisms other than cerebral accumulation of un phosphorylated glucose. In our study, activation increased CMRo2 by 16%. An increase of CMRo2 will increase the flux of metabolites through the glycolytic and oxidative pathways and cause upregulation of intermediary substrate pools. It is there fore possible that activation-induced excess glucose up take is caused by upregulation of intermediary substrate pools. According to these speculations the net release of glucose carbon observed in the recovery phase would be caused by the downregulation of substrate pools after normalization of cerebral oxygen consumption. If this hypothesis is correct a substantial part of the increase of cerebral glucose uptake observed during activation is as sociated with adjustment of intermediary substrate pools rather than with a net increase in cerebral energy pro duction.
